UCLA Health

Gamida Cell Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Company Update

Retrieved on: 
Wednesday, March 27, 2024
Capacity utilization, Diagnosis, Research, RSA, Bone marrow, TCT, Rituximab, Cell, General counsel, Health, Patient, EAP, Highbridge Capital Management, Society, Ronald Reagan, ATM, Depreciation, ID, Transplant, Therapy, Medicare, NK, CMS, Marketing, UCLA Health, Dentistry

BOSTON, March 27, 2024 (GLOBE NEWSWIRE) -- Gamida Cell Ltd. (Nasdaq: GMDA), a cell therapy pioneer working to turn cells into powerful therapeutics, today provided a business update and reported financial results for the fourth quarter and full year ended December 31, 2023.

Key Points: 
  • (Nasdaq: GMDA), a cell therapy pioneer working to turn cells into powerful therapeutics, today provided a business update and reported financial results for the fourth quarter and full year ended December 31, 2023.
  • Gamida Cell will become a private company, wholly owned by Highbridge, and the company’s outstanding ordinary shares are expected to be canceled.
  • The company has confirmed coverage with payers who cover more than 90% of commercial lives, exceeding the 2023 goal of 70%.
  • The full year Net Revenue included $1.1 million of net review for the fourth quarter of 2023.

Paragonix Technologies Announces Nationwide Commercial Availability of FDA-Cleared BAROguard™ Donor Lung Preservation System

Retrieved on: 
Thursday, April 4, 2024
FDA, Health Technology, Health, Medical Devices, Lung, Massachusetts General Hospital, International Society, Transplant, Patient, Duke University Hospital, Research, Standard of care, Lung transplantation, MD, Surgeon, MSC, UCSF Medical Center, Atmosphere, Hospital, UCLA, Heart, UCLA Health, Medical device

Paragonix Technologies, Inc. , a pioneer in organ transplant technologies and procurement services, announces the full commercial launch of its next-generation transport device, the BAROguard™ Donor Lung Preservation System .

Key Points: 
  • Paragonix Technologies, Inc. , a pioneer in organ transplant technologies and procurement services, announces the full commercial launch of its next-generation transport device, the BAROguard™ Donor Lung Preservation System .
  • First-of-its-kind, the novel BAROguard system combines clinically proven hypothermic preservation techniques alongside active airway management control to ensure that donor lungs maintain optimal conditions during transport for maximum protection.
  • Paragonix Technologies received FDA 510(k) clearance for the device in August 2023, and conducted its first-in-human case at Duke University Medical Center in November 2023.
  • “The commercial launch of BAROguard represents a significant breakthrough for the organ transplantation industry,” said Dr. Lisa Anderson, CEO and President of Paragonix Technologies.

UCLA and PreciseDx Announce New Collaboration to Advance AI-Enabled Predictions and Risk Mitigation for Triple-Negative Breast Cancer Recurrence

Retrieved on: 
Tuesday, April 2, 2024
HER2, Brain, Algorithm, Entrepreneurship, Immunotherapy, Disease, Risk, UCLA Health, Patient, Triple-negative breast cancer, Neoplasm, Research, MD, Medicine, Hospital, Breast cancer, Risk assessment, Pathology, Prognosis, Medical laboratory, Recurrence, TNBC, UCLA, Artificial intelligence, Health, Medical imaging

NEW YORK, April 2, 2024 /PRNewswire/ -- PreciseDx®, a leading innovator in oncology diagnostics leveraging Artificial Intelligence (AI) for revolutionary, morphology-driven disease analysis, today announced a sponsored research collaboration with UCLA's Department of Pathology and Laboratory Medicine in Los Angeles to evaluate PreciseBreast's™ ability to accurately assess risk of recurrence for patients with triple-negative breast cancer (TNBC). TNBC constitutes only 10-20% of all breast cancer cases, yet continues to demand significant clinical interest due to its limited response to conventional treatments, the association with younger women, BRCA1/2 mutations, ethnic/racial disparities, and its highly aggressive characteristics. 

Key Points: 
  • Our collaboration with PreciseDx has the potential to greatly improve our approach to predicting and managing recurrence in TNBC patients, ultimately leading to enhanced outcomes."
  • Integrating advanced AI algorithms and comprehensive clinical data, the collaborative study aims to confirm PreciseBreast as a highly effective and reliable digital breast cancer assay.
  • This new assay will potentially enhance the early detection of TNBC recurrence and support personalized treatment strategies tailored to individual patient needs.
  • The collaborative study between UCLA and PreciseDx represents a significant step forward in digital pathology and oncology breast cancer research.

NEW BOOK ENERGIZES MID-CAREER WOMEN BY PROMOTING INTENTIONAL SELF-ADVOCACY AND REJECTING SOCIETAL NORMS THAT HOLD WOMEN BACK

Retrieved on: 
Tuesday, March 19, 2024
Salvatore Ferragamo S.p.A., The Wall Street Journal, Next, USA Today, Zeal, The New York Times, Woman, The Ritz-Carlton Hotel Company, The Cheesecake Factory, Talent, Sale, University, Heel, Barnes & Noble, Publishing, Delta Air Lines, Multimedia, UCLA Health, Management

The book is on sale now via Amazon , Barnes & Noble , Amplify Publishing , and other major retailers.

Key Points: 
  • The book is on sale now via Amazon , Barnes & Noble , Amplify Publishing , and other major retailers.
  • Cynthia Bentzen-Mercer, cofounder of The Zeal of the Heel and founder of Bentzen Performance Partners, is a business executive, human capital strategist, author, and executive coach.
  • Kimberly is also the Wall Street Journal and USA Today bestselling author of Business Success Secrets.
  • Now, Near, Next is on sale now from Amazon , Barnes & Noble , Amplify Publishing , and other major retailers.

CrownLine to Launch 'Jupiter Column': Community for People to Leverage Proprietary Method Illuminating Human Relationship Chemistry

Retrieved on: 
Friday, February 16, 2024
Online, Engineering, Anxiety, Algorithm, Mental health, Student, Connected, Chemistry, University, Suicide, Thought, Family tree, Loneliness, Calendar, Stroke, Club, Sport, Season, Risk, Health, Depression, Autumn, Population health, Family, Dementia, Public, Medicine, Bullying, UCLA Health, Number, Music, Charm bracelet, Online shopping

LOS ANGELES, Feb. 16, 2024 /PRNewswire-PRWeb/ -- CrownLine (www.crownline.io), a company focused on illuminating human relationship chemistry, announced it will launch in the month of March 2024 "Jupiter Column", the community of CrownLine. Available to members via subscription, people can learn, and personally benefit from, the CROWNLINE Method to enhance and understand their human relationships -- be they identifying and connecting with individuals for friendship, family, business, potential significant others, and even a soulmate.

Key Points: 
  • LOS ANGELES, Feb. 16, 2024 /PRNewswire-PRWeb/ -- CrownLine ( www.crownline.io ), a company focused on illuminating human relationship chemistry, announced it will launch in the month of March 2024 "Jupiter Column", the community of CrownLine.
  • CrownLine Founder and CEO Todd Anthony Person has spent over two decades studying and building the foundation that would become the CrownLine Method.
  • The deck of playing cards was originally used as a calendar: there are 52 cards representing the 52 weeks in the year.
  • "Having confidence in one's relationships is key to mental health, and CrownLine intends to develop mentorship programs as part of its community relations efforts," commented Person.

Octave Welcomes Two Seasoned Healthcare Leaders to Its Board

Retrieved on: 
Thursday, February 8, 2024
Health, Health equity, Mental, SAN, Amazon, 1Life Healthcare, Public health, Acquisition, EVP, Growth, Stanford University Medical Center, Mental health, Harvard University, Optum, Divisional patent application, Health policy, Patient, UCLA Health, UnitedHealth Group, IPO, Fellow

"At Octave, we believe that the next chapter of our evolution as a mental health system is going to be moving from increasing access to increasing the effectiveness of care. This kind of change takes collaborative partnerships between innovators and the established institutions that define our healthcare system," said Sandeep Acharya, Octave's Founder and CEO. "Amir and Andrew are both deeply experienced healthcare leaders who are passionate about bringing change to the system--and we look forward to having their guidance through our next chapter."

Key Points: 
  • SAN FRANCISCO, Feb. 8, 2024 /PRNewswire/ -- Octave , an innovator in outcomes-focused behavioral health care, today announced that it has named two seasoned healthcare leaders to its Board of Directors.
  • The new members bring deep experience in the healthcare industry and will provide strategic guidance to position Octave as the leading in-network partner for mental health care.
  • "I am delighted to join the Octave Board and have Healthier Capital invest in such an impactful organization focused on increasing access to clinically-effective, high-quality, in-network behavioral healthcare," said Rubin.
  • "I look forward to working with the Board and Octave leadership in deepening this work across the country."

AHIMA Announces 2024 Board President/Chair, New Board Members

Retrieved on: 
Thursday, January 18, 2024
MCS, Lakeland Community College, RHIT, CCS, University, Risk, Journal, Doctor of Philosophy, Cuyahoga Community College, Information management, Community college, Commission, HIM, CHPS, Coppin, UCLA Health, AHIMA, Rehabilitation, Health information management, Coppin State University, MBA, Accreditation, MSML, Informatics, Injunction, CDI, Cuyahoga, Texas Health Resources, Advisory board, FACEP, Management

CHICAGO, Jan. 18, 2024 (GLOBE NEWSWIRE) -- Members of the American Health Information Management Association (AHIMA) elected Mona Calhoun, PhD, MS, Med, RHIA, FAHIMA, as president/chair of the 2024 AHIMA Board of Directors.

Key Points: 
  • CHICAGO, Jan. 18, 2024 (GLOBE NEWSWIRE) -- Members of the American Health Information Management Association (AHIMA) elected Mona Calhoun, PhD, MS, Med, RHIA, FAHIMA, as president/chair of the 2024 AHIMA Board of Directors.
  • "I look forward to working closely with our dynamic, visionary, and committed Board members in 2024," expressed Dr. Klauer.
  • In addition to Calhoun's appointment, AHIMA members selected a president/chair-elect and three new members of the Board of Directors (each of whom will serve a three-year term).
  • Additionally, she helped author the AHIMA CDI Toolkit, participated in the AHIMA Future of the House Taskforce and the AHIMA Envisioning Collaborative, and is an AHIMA Mentor.

HDI Delivers the Latest Trends in Support and Service Management at SupportWorld Live 2024

Retrieved on: 
Wednesday, January 17, 2024
Technology, Consulting, Marketing, Communications, Telecommunications, Professional Services, Business, Digital Marketing, Data Analytics, VoIP, Community, Thought, Biology, Uncertainty, Lead, Life, Sasuke (TV series), AI, Workplace, Career ladder, American Ninja Warrior, UCLA Health, UCLA, Fear, Health, Organization, Into, NASCAR, Education, Reality, Communication, Scheele, Management

Scheele will share how to challenge norms and embrace creativity, which leads to positive change and new summits.

Key Points: 
  • Scheele will share how to challenge norms and embrace creativity, which leads to positive change and new summits.
  • In a remote and hybrid work world, it can be hard for team members to find this support.
  • Alex Weber, award-winning entertainer and American Ninja Warrior will present “UNSTOPPABLE.” In the fast-changing world of IT support and service management, everyone faces setbacks, fears, negativity, pressures, and uncertainty.
  • To learn more about HDI’s SupportWorld Live or to register for the event, click here .

CORE Kidney's “Gift of Life: A Tune That Never Fades” Float Wins the Hearts of Rose Parade® Crowd, Recognized With 2024 Isabella Coleman Award

Retrieved on: 
Tuesday, January 16, 2024
General Health, Other Health, Health, Events, Concerts, Entertainment, Nephrology, Kidney, Patient, Rose Parade, Therapy, MD, Professor, Butterfly, Multimedia, Survivor, Flower, Kidney disease, DaVita Inc., Tournament, UCLA Health, Fear, Neuropsychology, Doctor of Philosophy, Education, Pharmaceutical industry

A special thanks to Lyn Lofthouse for the floral decorations that won us the Isabella Coleman Award.

Key Points: 
  • A special thanks to Lyn Lofthouse for the floral decorations that won us the Isabella Coleman Award.
  • We are also very grateful to Steve Perry and the Tournament of Roses team for supporting us all along.
  • The float with the kidney-shaped tree sat living kidney donors, kidney health champions, in a beautiful colorful garden as they danced to, “Dancing in the Streets” tune!
  • CORE Kidney’s Rose Parade float was sponsored by Amgen, Baxter International, DaVita and Travere Therapeutics, who made it possible to feature living kidney donors on the float.

The Conrad N. Hilton Foundation Welcomes Four New Members to the Board of Directors

Retrieved on: 
Tuesday, January 9, 2024
Foundation, Socially Responsible Investing, Professional Services, Philanthropy, Legal Affairs, Audit, Vanderbilt University, Knowledge, Travel Sentry, Business administration, International law, University, Violence, Hilton Towers, Hilton Worldwide, Poverty, The arts, The Walt Disney Company, Talent, School, Harvard Law School, UCLA Health, Organization, Heal the Bay, Death, AMH, American Homes 4 Rent, Air Lease Corporation, Airport, SPCA, New Village Leadership Academy, Multimedia, Concierge, Compensation, Humane society, Columbia University, Westgate Las Vegas, Statler, Hotel

Equally critical is identifying individuals with professional expertise and perspective to advance the Foundation’s mission.”

Key Points: 
  • Equally critical is identifying individuals with professional expertise and perspective to advance the Foundation’s mission.”
    The board of directors at the Hilton Foundation is made up of a majority of Hilton family members.
  • The new board members, two Hilton family members and two non-family members, bring an array of personal interests and professional expertise to the Foundation’s board of directors.
  • “It is a true honor to be joining the board of directors at the Conrad N. Hilton Foundation,” said Matthew J. Hart.
  • “I am thrilled to be joining the board of directors at the Conrad N. Hilton Foundation,” said Louise Nelson.